Published in Blood Weekly, December 15th, 2005
According to recent research published in the journal Bioorganic & Medicinal Chemistry Letters, "The semisynthesis, in vitro and in vivo biological evaluation of corosolic acid (1) and maslinic acid (2) are described."
X.A. Wen and colleagues at the China Pharmaceutical University in Nanging offered, "Compounds 1 and 2 represent a new class of inhibitors of glycogen phosphorylases. Both 1 and 2 inhibit the increase of fasted plasma glucose of diabetic mice induced by adrenaline."
"It is therefore...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.